1. Home
  2. CTMX vs PGP Comparison

CTMX vs PGP Comparison

Compare CTMX & PGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • PGP
  • Stock Information
  • Founded
  • CTMX 2008
  • PGP 2003
  • Country
  • CTMX United States
  • PGP United States
  • Employees
  • CTMX N/A
  • PGP N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • PGP Finance Companies
  • Sector
  • CTMX Health Care
  • PGP Finance
  • Exchange
  • CTMX Nasdaq
  • PGP Nasdaq
  • Market Cap
  • CTMX 85.3M
  • PGP 91.0M
  • IPO Year
  • CTMX 2015
  • PGP N/A
  • Fundamental
  • Price
  • CTMX $0.79
  • PGP $7.98
  • Analyst Decision
  • CTMX Buy
  • PGP
  • Analyst Count
  • CTMX 6
  • PGP 0
  • Target Price
  • CTMX $5.77
  • PGP N/A
  • AVG Volume (30 Days)
  • CTMX 764.2K
  • PGP 39.8K
  • Earning Date
  • CTMX 03-10-2025
  • PGP 01-01-0001
  • Dividend Yield
  • CTMX N/A
  • PGP 10.84%
  • EPS Growth
  • CTMX N/A
  • PGP N/A
  • EPS
  • CTMX 0.16
  • PGP N/A
  • Revenue
  • CTMX $126,617,000.00
  • PGP N/A
  • Revenue This Year
  • CTMX $22.55
  • PGP N/A
  • Revenue Next Year
  • CTMX N/A
  • PGP N/A
  • P/E Ratio
  • CTMX $4.79
  • PGP N/A
  • Revenue Growth
  • CTMX 33.66
  • PGP N/A
  • 52 Week Low
  • CTMX $0.75
  • PGP $5.83
  • 52 Week High
  • CTMX $5.85
  • PGP $7.81
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 40.57
  • PGP 54.91
  • Support Level
  • CTMX $0.82
  • PGP $7.94
  • Resistance Level
  • CTMX $0.98
  • PGP $8.04
  • Average True Range (ATR)
  • CTMX 0.07
  • PGP 0.08
  • MACD
  • CTMX -0.00
  • PGP 0.01
  • Stochastic Oscillator
  • CTMX 19.35
  • PGP 66.67

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About PGP Pimco Global StocksPlus & Income Fund of Beneficial Interest

PIMCO Global Stocksplus & Income Fund is a closed-end management investment company. The objective of the fund is to seek a total return comprised of current income, current gains, and long-term capital appreciation. The fund invests a majority of the fund's net assets in a combination of securities and instruments that provide exposure to stocks and or produce income.

Share on Social Networks: